RelayPro Thoracic Stent-Graft System 28-N4-44-209-44URecalls & reported problems
Bolton Medical Inc. · Endovascular Stent-Graft System · Class 3 · Implant
All models of RelayPro Thoracic Stent-Graft System (127)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
2 open recalls name this device. See the recall details and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 2
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00843576150782), received between Jul 15, 2025 and Jul 15, 2025 — classified as 1 injury.
The most frequently reported specific device problem is “Material Deformation” (1 report).
2 FDA recall records name this device's identifier, 2 still open.
1 other recall cover devices cleared under the same FDA submission (P200045); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Recalls naming this device
- Apr 22, 2026Class IOpen, Classified
Labeling update concerning proximal clasp disconnection from the outer control tube which may prevent stent graft from being released from the delivery system.
Z-2160-2026 · Root cause: Under Investigation by firm · Recall details · FDA record ↗
- Dec 20, 2022Class IIOpen, Classified
The product may be shorter than packaging indicates
Z-0998-2023 · Root cause: Labeling Change Control · Recall details · FDA record ↗
Most reported problems
Device problems
- Material Deformation1
- No Apparent Adverse Event1
Patient problems
- No Clinical Signs, Symptoms or Conditions1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryJul 15, 2025Material Deformation; No Apparent Adverse Event; Material Deformation; No Apparent Adverse Event
"STENT-GRAFT INFOLDING OF UNKNOWN CAUSE: FOR TREATMENT OF DESCENDING AORTIC ANEURYSM, THE STENT-GRAFT CONCERNED (28-N4-44-209-44U) WAS PLACED PROXIMALLY AND A STENT-GRAFT (28-N4-34-109-34U) WAS PLACED DISTALLY. THERE WAS ALSO AN AORTIC ARCH ANEURYSM, AND THE LESSER CURVATURE SIDE OF THE FIRST STENT OF THE PROXIMAL STENT-GRAFT PROTRUDED APPROXIMATELY 1 CM INTO THE ANEURYSM (BIRD BEAK). HOWEVER, THERE WAS NO ENDOLEAK, AND THE PROCEDURE WAS COMPLETED. POST-OPERATIVE CT SCAN REVEALED SIGNIFICANT INFOLDING FROM THE FIRST TO SECOND STENT ON THE LESSER CURVATURE SIDE AND CONTRAST MEDIUM HAD FLOWED OUTSIDE THE STENT-GRAFT. HOWEVER, NO ENDOLEAK WAS OBSERVED, SO NO ADDITIONAL TREATMENT WAS REQUIRED. OPERATION TYPE: STENT-GRAFTING BLOOD LOSS: UNKNOWN NO IMAGE AVAILABLE DUE TO HOSPITAL POLICY PRE-CASE PLAN AVAILABLE: SCHEMA ATTACHED ADDITIONAL INFORMATION WILL BE OBTAINED UPON REQUEST DELIVERY SYSTEM WAS DISCARDED BY USER ANCILLARY DEVICES USED: 28-N4-34-109-34U. (TC# (B)(4). PATIENT OUTCOME: "NO HARM TO THE PATIENT'S HEALTH."
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22512893 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under P200045. One submission often covers many models, so check the product and lot details in each record.
- Z-1383-2024 · Feb 22, 2024 · CompletedRELAY PRO Thoracic Stent-Graft System, containing one endovascular stent-graft system, IFU, and patient tracking card, sterile: (a) Part number 28-M4-34-100-34U; (b) Part number 2
Other System, Endovascular Graft, Aortic Aneurysm Treatment devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026 · each recall links to the FDA recall notice
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page